bioMérieux Stock Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 8.14B 9.25B 7.56B 6.95B 13.04B 896B 13.27B 90.41B 35.27B 437B 34.74B 33.99B 1,516B | P/E 2026 * |
16.6x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 7.7B 8.76B 7.16B 6.58B 12.34B 848B 12.56B 85.57B 33.38B 414B 32.88B 32.17B 1,435B | EV / Sales 2026 * |
1.88x | EV / Sales 2027 * | 1.69x |
| Free-Float |
33.22% | Yield 2026 * |
1.56% | Yield 2027 * | 1.64% |
Last Transcript: bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 2023-06-30 |
| Director of Finance/CFO | 50 | 2018-02-28 | |
| Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 2017-12-14 | |
| Director/Board Member | 66 | 2004-12-31 | |
| Director/Board Member | 61 | 2012-05-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.25% | - | - | 9.4B | |
| -0.36% | -3.10% | +230.47% | +298.83% | 19.99B | |
| -0.84% | -1.31% | +41.50% | +18.49% | 6.81B | |
| +2.15% | +8.05% | +252.86% | -19.85% | 5.97B | |
| -1.59% | +8.49% | -13.14% | -23.02% | 5.62B | |
| -10.00% | +9.69% | +88.17% | +110.73% | 5.06B | |
| +1.76% | -5.04% | -47.89% | - | 4.35B | |
| 0.00% | -4.24% | -26.67% | -28.44% | 4.05B | |
| -1.68% | -0.86% | -16.61% | -39.76% | 2.76B | |
| +0.92% | -10.54% | -35.91% | +204.93% | 1.6B | |
| Average | -0.99% | -1.59% | +52.53% | +65.24% | 6.25B | |
| Weighted average by Cap. | -0.88% | -1.77% | +113.01% | +125.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.11B 4.67B 3.81B 3.51B 6.58B 452B 6.7B 45.61B 17.79B 220B 17.52B 17.14B 765B | 4.37B 4.97B 4.06B 3.74B 7.01B 481B 7.13B 48.57B 18.95B 235B 18.66B 18.26B 815B |
| Net income | 495M 563M 460M 423M 794M 54.55B 808M 5.5B 2.15B 26.61B 2.11B 2.07B 92.31B | 554M 630M 515M 474M 888M 61.02B 904M 6.16B 2.4B 29.76B 2.37B 2.31B 103B |
| Net Debt | -436M -496M -405M -372M -698M -47.99B -711M -4.84B -1.89B -23.41B -1.86B -1.82B -81.21B | -757M -861M -703M -647M -1.21B -83.36B -1.23B -8.41B -3.28B -40.66B -3.23B -3.16B -141B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
